Literature DB >> 20956872

[Clinical, virological and epidemiological aspects of acute B hepatitis in the Catania area (Italy)].

Guido Scalia1, Raffaela Russo, Ilenia Palermo, Maria Gussio, Francesco Bellissimo, Filippo Fatuzzo, Arturo Montineri, Ildebrando Patamia, Maria Costanzo, Daniela Zappala, Rosario Russo, Bruno Cacopardo.   

Abstract

Starting from January 1997 we prospectively evaluated all cases of acute hepatitis B admitted to two of the main Infectious Diseases Units in Catania (eastern Sicily). The survey was extended throughout a 10-year period up to December 2007. Between 1997 and 1999 we observed 21 cases of acute hepatitis B; between 2000 and 2002 18 cases; between 2003 and 2005 22 cases and, finally, 37 cases were reported in the period 2006-2007. We found an increase in acute hepatitis B cases among people aged 26 to 44 years (from 38% in 1997-99 to 70% in 2006-07). A progressive decrease in intravenous drug abuse as a risk factor for acute hepatitis B was also observed (from 61% to 14%) together with a parallel increase in cases due to sexual transmission (from 19% to 56%) and outpatient cosmetic surgical procedures. Mean time to serum HBsAg negativization was longer in the last period (2006-07), with 6 cases out of 37 showing HBsAg persistence beyond 12 months from the clinical onset. Furthermore, in 2006-07 there were 12 cases (42%) of acute hepatitis due to HBV genotypes A and F. In our area, a progressive drop of hepatitis B cases due to intravenous drug abuse occurred, whereas heterosexual and iatrogenic cases increased. Cases due to HBV non-D genotypes may well be related to migration from endemic areas towards Sicily.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956872

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  1 in total

1.  Clinical, epidemiological and virological features of acute hepatitis B in Italy.

Authors:  Ornella Zuccaro; Luisa Romanò; Alfonso Mele; Andrea Mariano; Massimo Clementi; Maria Elena Tosti; Gloria Taliani; Claudio Galli; Alessandro Remo Zanetti; Enea Spada
Journal:  Infection       Date:  2015-02-20       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.